| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1100992786 |
| P356 | DOI | 10.1186/S12885-018-4024-3 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s12885-018-4024-3 |
| P932 | PMC publication ID | 5812229 |
| P698 | PubMed publication ID | 29439651 |
| P2093 | author name string | Frank Sullivan | |
| Kim Lazare | |||
| Gavin C W Chu | |||
| P2860 | cites work | miR-Test: A Blood Test for Lung Cancer Early Detection | Q56779122 |
| Estimating individual risk for lung cancer | Q83888138 | ||
| Lung cancer epigenetics: emerging biomarkers | Q28285049 | ||
| Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention | Q28388931 | ||
| Screening for lung cancer: A systematic review and meta-analysis | Q30251470 | ||
| STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies | Q30278455 | ||
| Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era | Q34840130 | ||
| Potential biomarkers for lung cancer screening | Q35200580 | ||
| EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays | Q36285345 | ||
| Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial | Q36305136 | ||
| Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. | Q36925169 | ||
| The state of molecular biomarkers for the early detection of lung cancer | Q37044593 | ||
| Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs | Q37128760 | ||
| Cancer incidence and mortality projections in the UK until 2035. | Q37426713 | ||
| Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers | Q38238438 | ||
| Screening and early detection efforts in lung cancer | Q38340341 | ||
| Current and future molecular diagnostics in non-small-cell lung cancer. | Q38543780 | ||
| Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice | Q43436848 | ||
| Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. | Q51181963 | ||
| Principles of Cancer Screening. | Q54535253 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genetic testing | Q285223 |
| biomarker | Q864574 | ||
| mass screening | Q64733553 | ||
| tumor biomarker | Q66205818 | ||
| early detection of cancer | Q66770492 | ||
| lung neoplasm | Q15124212 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 181 | |
| P577 | publication date | 2018-02-13 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Serum and blood based biomarkers for lung cancer screening: a systematic review. | |
| P478 | volume | 18 |
| Q104079208 | Clinical significance and prognostic value of Porphyromonas gingivalis infection in lung cancer |
| Q64967050 | Comparison of value of biomarkers in diagnosing lung cancer: An overview of systematic reviews protocol. |
| Q92041491 | Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non-small cell lung cancer: A meta-analysis |
| Q59129088 | Metabolome-based biomarkers: their potential role in the early detection of lung cancer |
| Q92260304 | Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung |
| Q98159012 | Overexpression of miR-518b in non-small cell lung cancer serves as a biomarker and facilitates tumor cell proliferation, migration and invasion |
| Q92276509 | Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer |
| Q59800539 | The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis |
| Q57178576 | The narrow path to organized LDCT lung cancer screening programs in Europe |
Search more.